SlideShare a Scribd company logo
PRESENTED BY:Dr Sachin Giri
Moderator:Dr Nikhil Gupta
Assistant Professor
 Definitions
 Stages of platelets Developement
 Causes
 Approach to Thrombocytopenic Patient
 Diagnosis
 Treatment
 Thrombocytopenia is defined as an count
less than 150000/mm₃
 Pseudothrombocytopenia –Blood collected
in EDTA tube leads to platelets clumping due
to the presence of antibodies usually IgG but
also IgM IgA
Decreased Production
 Hematologic malignancies
 Aplastic anemia
 Myelodysplasia
 Drugs: chemotherapy, alcohol
 Radiation
 HIV
 Hereditary thrombocytopenias
 Metastatic cancer to bone marrow
 Immune
1. ITP
2. HIT
3. Drug-induced antibodies
4. HIV
5. post transfusion purpura
6. Connective tissue diseases
 Nonimmune
1. DIC
2. Sepsis
3. TTP-HUS
4. Kasabach Merrit syndrome
 Sequestrations
1. Hypersplenism
Histoty
 usually asymptomatic
 Presence of petechiae, ecchymoses
 Mucocutaneous bleeding
 Purpura
 Rarely central nervous system bleeding
 retinal hemorrhages
History of…
 Recent Infections
 Malignancies
 Pregnancy status in premenopausal woman
 Recent medications
 Vaccinations
 Recent travels
 Recent transfusions
 Recent organ transplantation
 Family history of thrombocytopenia
 Autoimmune disorders
 presence of petechiae ecchymosis in the skin,
 wet purpura in mucous membranes
 Splenomegaly
 The presence of retinal hemorrhage on ocular
fundus examination is a predictor of CNS
hemorrhage
 Complete blood counts
 Peripheral blood smear
 D-dimer
 Serum LDH
 Bone marrow examinations
 HIV
 ESR
 hsCRP
 Due to the presence of naturally occurring
antibodies that cross-react with the drug bound
to the platelet.
 The thrombocytopenia occurs after a period of
initial exposure of 21 days
 Resolves in 7–10 days after drug withdrawal.
 Abciximab exposure causes thrombocytopenia
within 24 h of initial exposure.
 Penicillin
 Phenytoin
 Piperacillin
 Abciximab
 NSAIDs
 Amiodarone
 Amlodipine
 Ampicillin
 Carbamazepine
 Ceftriaxone
 Cephamandole
 Ciprofloxacin
 Diazepam
 Eptifibatide
 Furosemide
 Vancomycin
 The thrombocytopenia is not usually severe,
rarely <20,000/μL.
 Heparin-induced thrombocytopenia (HIT) is
not associated with bleeding, it increases the
risk of thrombosis.
 Antibodies to complex of platelet factor 4
and heparin
 HIT after exposure to heparin for 5–14 days.
HIT (anti-heparin/PF4) antibodies can be
detected using two types of assays.
The most widely available is an enzyme-linked
immunoassay (ELISA).
The other assay is a platelet activation assay,
most commonly the serotonin release assay,
 Direct thrombin inhibitor (DTI)
- Argatroban
-Fondaparinux
 Xa Inhibitor-Danaparoid
 Warfarin therapy.
 Immune thrombocytopenic purpura (ITP); is an
acquired disorder
 It is immune-mediated destruction of platelets
and inhibition of platelet release from the
megakaryocyte.
 In children, it is usually an acute disease.
 In adults, it is a more chronic disease.
 Secondary ITP if it is associated with an
underlying disorder;
 autoimmune disorders, particularly systemic
lupus erythematosus (SLE),
 infections, such as HIV and hepatitis C.
 ITP is characterized by mucocutaneous
bleeding and a low, often very low platelet
count, with an otherwise normal peripheral
blood cells and smear.
 Patients usually present either with
ecchymoses and petechiae.
 Mucocutaneous bleeding may be present.
Rarely, life-threatening, including central
nervous system bleeding can occur.
 retinal hemorrhages
 prednisone at 1 mg/kg,
 Anti Rh0(D) immune globulin at 50–75
μg/kg,
Monitoring patients for 8 h after infusion
 Intravenous gamma globulin (IVIgG)
 splenectomy
 Eltrombopag is FDA approved for use in children
over 1 year of age.
 Romiplostim is not yet FDA approved in children
but a randomized trial supports efficacy.
 Immunosuppressive drugs- mycophenolate mofetil
dapsone.
 TTP is related to a deficiency or antibodies
to the metalloprotease ADAMTS13, which
cleaves VWF.
 ADAMTS13 activity levels of <10% are more
clearly associated with antibody-mediated
TTP.
 Idiopathic TTP appears to be more common
in women than in men.
 plasma exchange
 It decreases mortality from 85–100% to 10–
30%.
 HUS is a syndrome characterized
1) Acute renal failure
2) Microangiopathic hemolytic anemia,
3) Thrombocytopenia.
 Escherichia coli O157:H7 is the most frequent
causative agent
 Atypical HUS (aHUS) is usually due to genetic
defects that result in chronic complement
activation or antibodies directed against
complement regulatory proteins.
Indications of platelets tranfusion
 10,000/uL - prophylactic transfusion
 20,000/uL - in the presence of bleeding,
fever, infection, platelet function defect, or
coagulopathy
 50,000/uL - prior to minor procedures, in
actively anticoagulated patients or in the
presence of active bleeding
 75,000/uL - prior to general surgery
 100,000/uL - prior to neurologic or
ophthalmologic surgery
 Random donor platelet
 Single donor platelet
 Thrombocytopenia if platletes <150000/ul
then Pseudothrombocytopenia should be
ruled out
 Proper history taking and examination for
finding out of different causes
 Peripheral blood smear to find out causes
 Indications of platelets transfusion
<10000/ul
 Harissons 20th
 Wintrobes clinical hematology
Thrombocytopenia

More Related Content

What's hot

Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
Ali Hammosh
 
Platelet disorders
Platelet disordersPlatelet disorders
Platelet disorders
mfabzak
 
CME thrombocytopenia
CME thrombocytopeniaCME thrombocytopenia
CME thrombocytopeniaAlaa Habbal
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
Diana Girnita
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
Jigar Padalia
 
OVERVIEW Disorders of platelets
OVERVIEW Disorders of plateletsOVERVIEW Disorders of platelets
OVERVIEW Disorders of platelets
Vidur Singh
 
An approach to a patient with Thrombocytopenia
An approach to a patient with ThrombocytopeniaAn approach to a patient with Thrombocytopenia
An approach to a patient with Thrombocytopeniaaminanurnova
 
Platelet disorder with ITP
Platelet disorder with ITPPlatelet disorder with ITP
Platelet disorder with ITP
Nahar Kamrun
 
Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP)Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP)
Dr. Renesha Islam
 
TTP HUS
TTP HUSTTP HUS
Idiopathic thrombocytopenic purpura
Idiopathic thrombocytopenic purpuraIdiopathic thrombocytopenic purpura
Idiopathic thrombocytopenic purpura
Ekta Patel
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
fitango
 
Idiopathic (autoimmune) Thrombocytopenic Purpura
Idiopathic (autoimmune) Thrombocytopenic PurpuraIdiopathic (autoimmune) Thrombocytopenic Purpura
Idiopathic (autoimmune) Thrombocytopenic Purpura
Dr. Saad Saleh Al Ani
 
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)student
 
Disseminated Intravascular Coagulation
Disseminated Intravascular CoagulationDisseminated Intravascular Coagulation
Disseminated Intravascular Coagulation
QURATULAIN MUGHAL
 
Thrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic PurpuraThrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic PurpuraShakeel Arif
 
Thrombotic Microangiopathy
Thrombotic MicroangiopathyThrombotic Microangiopathy
Thrombotic Microangiopathy
krishnaswamy sampathkumar
 
Idiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic PurpuraIdiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic Purpura
jayatheeswaranvijayakumar
 
Platelet disoders
Platelet disodersPlatelet disoders
Platelet disoders
pediatricsmgmcri
 

What's hot (20)

Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 
Platelet disorders
Platelet disordersPlatelet disorders
Platelet disorders
 
CME thrombocytopenia
CME thrombocytopeniaCME thrombocytopenia
CME thrombocytopenia
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 
OVERVIEW Disorders of platelets
OVERVIEW Disorders of plateletsOVERVIEW Disorders of platelets
OVERVIEW Disorders of platelets
 
An approach to a patient with Thrombocytopenia
An approach to a patient with ThrombocytopeniaAn approach to a patient with Thrombocytopenia
An approach to a patient with Thrombocytopenia
 
Platelet disorder with ITP
Platelet disorder with ITPPlatelet disorder with ITP
Platelet disorder with ITP
 
Platelet disorders
Platelet disordersPlatelet disorders
Platelet disorders
 
Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP)Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP)
 
TTP HUS
TTP HUSTTP HUS
TTP HUS
 
Idiopathic thrombocytopenic purpura
Idiopathic thrombocytopenic purpuraIdiopathic thrombocytopenic purpura
Idiopathic thrombocytopenic purpura
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 
Idiopathic (autoimmune) Thrombocytopenic Purpura
Idiopathic (autoimmune) Thrombocytopenic PurpuraIdiopathic (autoimmune) Thrombocytopenic Purpura
Idiopathic (autoimmune) Thrombocytopenic Purpura
 
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
medicine.Bleeding disorders.(dr.sabir) (new powerpoint)
 
Disseminated Intravascular Coagulation
Disseminated Intravascular CoagulationDisseminated Intravascular Coagulation
Disseminated Intravascular Coagulation
 
Thrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic PurpuraThrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic Purpura
 
Thrombotic Microangiopathy
Thrombotic MicroangiopathyThrombotic Microangiopathy
Thrombotic Microangiopathy
 
Idiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic PurpuraIdiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic Purpura
 
Platelet disoders
Platelet disodersPlatelet disoders
Platelet disoders
 

Similar to Thrombocytopenia

Disorders of platelets
Disorders of plateletsDisorders of platelets
Disorders of platelets
DR. JITHIN GEORGE
 
Medicine.Bleeding disorders.(dr.sabir)
Medicine.Bleeding disorders.(dr.sabir)Medicine.Bleeding disorders.(dr.sabir)
Medicine.Bleeding disorders.(dr.sabir)student
 
Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)
Rajesh S
 
Hemophilia and ITP
Hemophilia and ITPHemophilia and ITP
Hemophilia and ITP
Dr M Sanjeevappa
 
Diseminated Intravascular Coagulopathy And Others
Diseminated Intravascular Coagulopathy And OthersDiseminated Intravascular Coagulopathy And Others
Diseminated Intravascular Coagulopathy And OthersRHMBONCO
 
drug induced blood disorders.pptx
drug induced blood disorders.pptxdrug induced blood disorders.pptx
drug induced blood disorders.pptx
AyushiAlagiya
 
23 Ppt Itp
23 Ppt Itp23 Ppt Itp
23 Ppt Itpghalan
 
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptxDr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
dramit13
 
BLEEDING DISORDERS.pptx
BLEEDING DISORDERS.pptxBLEEDING DISORDERS.pptx
BLEEDING DISORDERS.pptx
EidleMohamedsaed
 
Disseminated Intravascular Coagulation
Disseminated Intravascular CoagulationDisseminated Intravascular Coagulation
Disseminated Intravascular Coagulation
Deep Deep
 
ITP by dr. Mohib Ali
ITP by dr. Mohib AliITP by dr. Mohib Ali
ITP by dr. Mohib Ali
Mohib Ali
 
ITP : idiopathic or immune thrombocytopenic purpure
ITP : idiopathic or immune thrombocytopenic purpure ITP : idiopathic or immune thrombocytopenic purpure
ITP : idiopathic or immune thrombocytopenic purpure
KaustubhPachade
 
Bleeding disorders in pregnancy
Bleeding disorders in pregnancyBleeding disorders in pregnancy
Bleeding disorders in pregnancydrmcbansal
 
Hematologic emergency
Hematologic emergencyHematologic emergency
Hematologic emergency
Kaipol Takpradit
 
Dic &amp; coagulation tests
Dic &amp; coagulation testsDic &amp; coagulation tests
Dic &amp; coagulation tests
Lailmaah habibi
 
APPROACH TO THROMBOCYTOPENIA.pptx
APPROACH TO THROMBOCYTOPENIA.pptxAPPROACH TO THROMBOCYTOPENIA.pptx
APPROACH TO THROMBOCYTOPENIA.pptx
SoubhagyaDas27
 
Rheumatology in ICU.pptx
Rheumatology in ICU.pptxRheumatology in ICU.pptx
Rheumatology in ICU.pptx
Mani Reddy
 
Idiopathicthrombocytopenicpurpura 151213171711
Idiopathicthrombocytopenicpurpura 151213171711Idiopathicthrombocytopenicpurpura 151213171711
Idiopathicthrombocytopenicpurpura 151213171711
98yayee
 
Thrombotic disorders
Thrombotic disordersThrombotic disorders
Thrombotic disorders
Somu Venkatesh
 

Similar to Thrombocytopenia (20)

Disorders of platelets
Disorders of plateletsDisorders of platelets
Disorders of platelets
 
Medicine.Bleeding disorders.(dr.sabir)
Medicine.Bleeding disorders.(dr.sabir)Medicine.Bleeding disorders.(dr.sabir)
Medicine.Bleeding disorders.(dr.sabir)
 
Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)
 
Hemophilia and ITP
Hemophilia and ITPHemophilia and ITP
Hemophilia and ITP
 
Diseminated Intravascular Coagulopathy And Others
Diseminated Intravascular Coagulopathy And OthersDiseminated Intravascular Coagulopathy And Others
Diseminated Intravascular Coagulopathy And Others
 
drug induced blood disorders.pptx
drug induced blood disorders.pptxdrug induced blood disorders.pptx
drug induced blood disorders.pptx
 
23 Ppt Itp
23 Ppt Itp23 Ppt Itp
23 Ppt Itp
 
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptxDr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
 
Mr 2.24.14
Mr 2.24.14Mr 2.24.14
Mr 2.24.14
 
BLEEDING DISORDERS.pptx
BLEEDING DISORDERS.pptxBLEEDING DISORDERS.pptx
BLEEDING DISORDERS.pptx
 
Disseminated Intravascular Coagulation
Disseminated Intravascular CoagulationDisseminated Intravascular Coagulation
Disseminated Intravascular Coagulation
 
ITP by dr. Mohib Ali
ITP by dr. Mohib AliITP by dr. Mohib Ali
ITP by dr. Mohib Ali
 
ITP : idiopathic or immune thrombocytopenic purpure
ITP : idiopathic or immune thrombocytopenic purpure ITP : idiopathic or immune thrombocytopenic purpure
ITP : idiopathic or immune thrombocytopenic purpure
 
Bleeding disorders in pregnancy
Bleeding disorders in pregnancyBleeding disorders in pregnancy
Bleeding disorders in pregnancy
 
Hematologic emergency
Hematologic emergencyHematologic emergency
Hematologic emergency
 
Dic &amp; coagulation tests
Dic &amp; coagulation testsDic &amp; coagulation tests
Dic &amp; coagulation tests
 
APPROACH TO THROMBOCYTOPENIA.pptx
APPROACH TO THROMBOCYTOPENIA.pptxAPPROACH TO THROMBOCYTOPENIA.pptx
APPROACH TO THROMBOCYTOPENIA.pptx
 
Rheumatology in ICU.pptx
Rheumatology in ICU.pptxRheumatology in ICU.pptx
Rheumatology in ICU.pptx
 
Idiopathicthrombocytopenicpurpura 151213171711
Idiopathicthrombocytopenicpurpura 151213171711Idiopathicthrombocytopenicpurpura 151213171711
Idiopathicthrombocytopenicpurpura 151213171711
 
Thrombotic disorders
Thrombotic disordersThrombotic disorders
Thrombotic disorders
 

Recently uploaded

Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 

Recently uploaded (20)

Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 

Thrombocytopenia

  • 1. PRESENTED BY:Dr Sachin Giri Moderator:Dr Nikhil Gupta Assistant Professor
  • 2.  Definitions  Stages of platelets Developement  Causes  Approach to Thrombocytopenic Patient  Diagnosis  Treatment
  • 3.  Thrombocytopenia is defined as an count less than 150000/mm₃  Pseudothrombocytopenia –Blood collected in EDTA tube leads to platelets clumping due to the presence of antibodies usually IgG but also IgM IgA
  • 4.
  • 5. Decreased Production  Hematologic malignancies  Aplastic anemia  Myelodysplasia  Drugs: chemotherapy, alcohol  Radiation  HIV  Hereditary thrombocytopenias  Metastatic cancer to bone marrow
  • 6.  Immune 1. ITP 2. HIT 3. Drug-induced antibodies 4. HIV 5. post transfusion purpura 6. Connective tissue diseases  Nonimmune 1. DIC 2. Sepsis 3. TTP-HUS 4. Kasabach Merrit syndrome  Sequestrations 1. Hypersplenism
  • 7. Histoty  usually asymptomatic  Presence of petechiae, ecchymoses  Mucocutaneous bleeding  Purpura  Rarely central nervous system bleeding  retinal hemorrhages
  • 8. History of…  Recent Infections  Malignancies  Pregnancy status in premenopausal woman  Recent medications  Vaccinations  Recent travels  Recent transfusions  Recent organ transplantation  Family history of thrombocytopenia  Autoimmune disorders
  • 9.  presence of petechiae ecchymosis in the skin,  wet purpura in mucous membranes  Splenomegaly  The presence of retinal hemorrhage on ocular fundus examination is a predictor of CNS hemorrhage
  • 10.  Complete blood counts  Peripheral blood smear  D-dimer  Serum LDH  Bone marrow examinations  HIV  ESR  hsCRP
  • 11.
  • 12.  Due to the presence of naturally occurring antibodies that cross-react with the drug bound to the platelet.  The thrombocytopenia occurs after a period of initial exposure of 21 days  Resolves in 7–10 days after drug withdrawal.  Abciximab exposure causes thrombocytopenia within 24 h of initial exposure.
  • 13.  Penicillin  Phenytoin  Piperacillin  Abciximab  NSAIDs  Amiodarone  Amlodipine  Ampicillin  Carbamazepine  Ceftriaxone  Cephamandole  Ciprofloxacin  Diazepam  Eptifibatide  Furosemide  Vancomycin
  • 14.  The thrombocytopenia is not usually severe, rarely <20,000/μL.  Heparin-induced thrombocytopenia (HIT) is not associated with bleeding, it increases the risk of thrombosis.  Antibodies to complex of platelet factor 4 and heparin  HIT after exposure to heparin for 5–14 days.
  • 15.
  • 16. HIT (anti-heparin/PF4) antibodies can be detected using two types of assays. The most widely available is an enzyme-linked immunoassay (ELISA). The other assay is a platelet activation assay, most commonly the serotonin release assay,
  • 17.  Direct thrombin inhibitor (DTI) - Argatroban -Fondaparinux  Xa Inhibitor-Danaparoid  Warfarin therapy.
  • 18.  Immune thrombocytopenic purpura (ITP); is an acquired disorder  It is immune-mediated destruction of platelets and inhibition of platelet release from the megakaryocyte.  In children, it is usually an acute disease.  In adults, it is a more chronic disease.  Secondary ITP if it is associated with an underlying disorder;  autoimmune disorders, particularly systemic lupus erythematosus (SLE),  infections, such as HIV and hepatitis C.
  • 19.  ITP is characterized by mucocutaneous bleeding and a low, often very low platelet count, with an otherwise normal peripheral blood cells and smear.  Patients usually present either with ecchymoses and petechiae.  Mucocutaneous bleeding may be present. Rarely, life-threatening, including central nervous system bleeding can occur.  retinal hemorrhages
  • 20.  prednisone at 1 mg/kg,  Anti Rh0(D) immune globulin at 50–75 μg/kg, Monitoring patients for 8 h after infusion  Intravenous gamma globulin (IVIgG)  splenectomy  Eltrombopag is FDA approved for use in children over 1 year of age.  Romiplostim is not yet FDA approved in children but a randomized trial supports efficacy.  Immunosuppressive drugs- mycophenolate mofetil dapsone.
  • 21.  TTP is related to a deficiency or antibodies to the metalloprotease ADAMTS13, which cleaves VWF.  ADAMTS13 activity levels of <10% are more clearly associated with antibody-mediated TTP.  Idiopathic TTP appears to be more common in women than in men.
  • 22.
  • 23.  plasma exchange  It decreases mortality from 85–100% to 10– 30%.
  • 24.  HUS is a syndrome characterized 1) Acute renal failure 2) Microangiopathic hemolytic anemia, 3) Thrombocytopenia.  Escherichia coli O157:H7 is the most frequent causative agent  Atypical HUS (aHUS) is usually due to genetic defects that result in chronic complement activation or antibodies directed against complement regulatory proteins.
  • 25. Indications of platelets tranfusion  10,000/uL - prophylactic transfusion  20,000/uL - in the presence of bleeding, fever, infection, platelet function defect, or coagulopathy  50,000/uL - prior to minor procedures, in actively anticoagulated patients or in the presence of active bleeding  75,000/uL - prior to general surgery  100,000/uL - prior to neurologic or ophthalmologic surgery
  • 26.  Random donor platelet  Single donor platelet
  • 27.  Thrombocytopenia if platletes <150000/ul then Pseudothrombocytopenia should be ruled out  Proper history taking and examination for finding out of different causes  Peripheral blood smear to find out causes  Indications of platelets transfusion <10000/ul
  • 28.  Harissons 20th  Wintrobes clinical hematology

Editor's Notes

  1. pseudothrombocytopenia,” particularly in a patient without an apparent cause for the thrombocytopenia. Pseudothrombocytopenia (Fig. 111-1B) is an in vitro artifact resulting from platelet agglutination via antibodies (usually IgG, but also IgM and IgA) when the calcium content is decreased by blood collection in ethylenediamine tetraacetic (EDTA) (the anticoagulant present in tubes collect blood for complete blood counts [CBCs]). If a low platelet count is obtained in EDTA-anticoagulated blood, a blood smear should be evaluated and a platelet count determined in blood collected into sodium citrate (blue top tube) or heparin (green top tube), or a smear of freshly obtained unanticoagulated blood, such as from a finger stick, can be examined
  2. Mucocutaneous bleeding such as oral mucosa, gastrointestinal, or heavy menstrual bleeding, may be present Wet purpura (blood blisters in the mouth) and retinal hemorrhages may herald life-threatening bleeding. Petechiae size <4 mm Petechiae are pinpoint, nonblanching hemorrhages and are usually a sign of a decreased platelet number and not platelet dysfunction. Echymosis flat blue or purple patch size about >1 cm Purpura small small purple spots size 4-10 mm
  3. Medical history can provide invaluable information and greatly facilitate diagnosis. Aspects of particular relevance that should be investigated include Congenital thrombocytopenia May-Hegglin anomaly, and Sebastian, Epstein’s, and Fechtner syndromes, all of which have distinct distinguishing features. A common feature of these disorders is large platelets (Fig. 111-1C). Autosomal recessive disorders include congenital amegakaryocytic thrombocytopenia, thrombocytopenia with absent radii, and Bernard-Soulier syndrome. The latter is primarily a functional platelet disorder due to absence of Gp Ib-IX-V, the VWF adhesion receptor. X-linked disorders include Wiskott-Aldrich syndrome recent travels (eg, malaria, rickettsiosis, dengue fever); Recent transfusions; alloimmune Thrombocytopenia
  4. Splenomegaly exclude any chronic liver ds, leukemia lymphoma other hematological malignancy
  5. Now I m going to discuss some important cause of thrombocytopenia one by one in brief
  6. HIT can occur after exposure to low-molecular-weight heparin (LMWH) as well as unfractionated heparin (UFH),it is more common with UFH HIT results from antibody formation to a complex of the platelet-specific protein platelet factor 4 (PF4) and heparin. The anti-heparin/PF4 antibody can activate platelets through the FcγRIIa receptor and also activate monocytes and endothelial cells. It occurs before 5 days in those who were exposed to heparin in the prior few weeks or months (<~100 days)
  7. Because many patients develop antibodies but do not develop clinical HIT, the test has a low specificity for the diagnosis of HIT. This is especially true in patients who have undergone cardiopulmonary bypass surgery, where ∼50% of patients develop these antibodies postoperatively. IgG-specific ELISAs increase specificity but may decrease sensitivity. which measures the ability of the patient’s serum to activate platelets in the presence of heparin in a concentration-dependent manner. This test has lower sensitivity but higher specificity than the ELISA. However, HIT remains a clinical diagnosis
  8. Warfarin if started, should be overlapped with a DTI or fondaparinux and started after resolution of the thrombocytopenia and lessening of the prothrombotic state
  9. (ITP; also termed idiopathic thrombocytopenic purpura) Childs most commonly following an infection, and with a self-limited course although in some adults, spontaneous remission occurs, usually within months of diagnosis Viruses like CMV,Infectious mononucleosis VZV, TUBECULOSIS H pylori
  10. Mucocutaneous bleeding such as oral mucosa, gastrointestinal, or heavy menstrual bleeding
  11. Eltrombopag oral s/e hepatotoxicity Romiplostim i/v in week
  12. TTP is related to a deficiency of, or antibodies to, the metalloprotease ADAMTS13, which cleaves VWF. which are then cleaved by ADAMTS13. The persistence of ultra-large VWF molecules is thought to contribute to pathogenic platelet adhesion and aggregation
  13. Laboratory testing for DNA variants in complement regulatory genes is available, although assigning pathogenicity to variants remains challenging. Currently there is not a functional assay that is diagnostic of the disease. It is seen preceded by an episode of diarrhea, often hemorrhagic in nature, predominantly in children.
  14. 1 unit RDP increases plts 5-8 thousands 1 units of SDP increases 30-50 thousands